TheraVet SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 1.08 million compared to EUR 1.6 million a year ago. Revenue was EUR 1.27 million compared to EUR 2 million a year ago.

Net loss was EUR 1.57 million compared to EUR 2.32 million a year ago. Basic loss per share from continuing operations was EUR 0.487.